No record found


* Returns not adjusted for payouts
Company Profile
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).
Ms. Erum Shakir Rahim | CEO |
Chairman | |
Ms. Mehar-e-daraksha Ameer | Company Secretary |
CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi
Yousuf Adil, Chartered Accountants
December
Equity Profile
Announcements
Date | Title | Document |
---|---|---|
Oct 28, 2022 | Transmission of Quarterly Report for the Period Ended September 30, 2022 | View PDF |
Oct 25, 2022 | Financial Results for the Quarter Ended September 30, 2022 | View PDF |
Aug 29, 2022 | Transmission of Quarterly Report for the Period Ended June 30, 2022 | View PDF |
Aug 23, 2022 | Financial Results for the Quarter Ended June 30, 2022 | View PDF |
May 6, 2022 | Transmission of Quarterly Report for the Period Ended March 31, 2022 | View PDF |
Apr 26, 2022 | Financial Results for the Quarter Ended March 31, 2022 | View PDF |
Apr 4, 2022 | Transmission of Annual Report for the Year Ended 2021-12-31 | View PDF |
Feb 25, 2022 | Financial Results for the Year Ended December 31 2021 | View PDF |
Oct 29, 2021 | Transmission of Quarterly Report for the Period Ended September 30, 2021 | View PDF |
Oct 25, 2021 | Financial Results for the Quarter Ended September 30, 2021 | View PDF |
Date | Title | Document |
---|---|---|
Oct 18, 2022 | Board Meeting | View PDF |
Aug 16, 2022 | Board of Directors Meeting - August 23, 2022 | View PDF |
Apr 25, 2022 | Board Meeting In Progress | View PDF |
Apr 25, 2022 | Certified True Copy of Resolution - Annual General Meeting | View PDF |
Apr 18, 2022 | Board Meeting | View PDF |
Apr 4, 2022 | Notice of Annual General Meeting | View PDF |
Feb 18, 2022 | BOARD OF DIRECTORS MEETING | View PDF |
Oct 18, 2021 | Board of Directors Meeting | View PDF |
Aug 20, 2021 | Board Meeting Reschedule | View PDF |
Aug 16, 2021 | Board of Directors Meeting | View PDF |
Date | Title | Document |
---|---|---|
Nov 24, 2022 | Notice of Corporate Briefing Session 2022 | View PDF |
Sep 28, 2022 | Appointment of Non-Executive Director | View PDF |
Sep 28, 2022 | Appointment of Non-Executive Director | View PDF |
Sep 16, 2022 | GLAXO | GlaxoSmithKline Pakistan Limited REVISED | |
Sep 16, 2022 | GLAXO | GlaxoSmithKline Pakistan Limited - Panadol Information REVOKED | |
Aug 12, 2022 | Appointment of Ms. Lai Kuen Goh - Chairperson and Non-Executive Director | View PDF |
Aug 10, 2022 | Resignation of Mr. Dmytro Oliinyk from the Board of GlaxoSmithKline Pakistan Limited | View PDF |
Jun 30, 2022 | Material Information - Resignation of Mark Dawson as Director w.e.f. 30 June 2022 | View PDF |
Jun 8, 2022 | Material Information | View PDF |
May 10, 2022 | Credit of Final Cash Dividend 2021 | View PDF |
Financials
All numbers in thousands (000's) except EPS
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
Sales | 36,660,772 | 35,090,112 | 36,581,749 | 34,006,840 |
Profit after Taxation | 5,354,409 | 3,375,240 | 3,041,123 | 3,257,951 |
EPS | 16.81 | 10.60 | 9.55 | 10.23 |
Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | |
---|---|---|---|---|
Sales | 11,925,662 | 9,542,377 | 8,625,964 | 9,825,226 |
Profit after Taxation | 148,664 | (293,829) | 925,041 | 1,195,203 |
EPS | 0.47 | (0.92) | 2.90 | 3.75 |

Ratios
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
Gross Profit Margin (%) | 26.56 | 21.47 | 21.08 | 24.74 |
Net Profit Margin (%) | 14.61 | 9.62 | 8.31 | 9.58 |
EPS Growth (%) | 58.58 | 10.99 | (6.65) | 9.29 |
PEG | 0.14 | 1.65 | (2.53) | 1.19 |
Payouts
Date | Financial Results | Details | Book Closure |
---|---|---|---|
February 28, 2022 11:32 AM | 31/12/2021(YR) | 70%(F) (D) | 19/04/2022 - 25/04/2022 |
March 10, 2021 3:45 PM | 31/12/2020(YR) | 65%(F) (D) | 21/04/2021 - 27/04/2021 |
March 11, 2020 5:58 PM | 31/12/2019(YR) | 60%(F) (D) | 15/05/2020 - 21/05/2020 |
March 4, 2019 4:53 PM | 31/12/2018(YR) | 70%(F) (D) | 18/04/2019 - 24/04/2019 |
February 27, 2018 3:59 PM | 31/12/2017(YR) | 40% (D) | 18/04/2018 - 24/04/2018 |
October 26, 2017 5:47 PM | 30/09/2017(IIIQ) | 30% (D) | 10/11/2017 - 17/11/2017 |
March 8, 2017 4:03 PM | 31/12/2016(YR) | 60% (D) | 18/04/2017 - 24/04/2017 |
March 30, 2016 3:13 PM | 31/12/2015(YR) | 40% (D) | 20/04/2016 - 27/04/2016 |
February 25, 2015 3:51 PM | 31/12/2014(YR) | 50% (D) | 16/04/2015 - 23/04/2015 |
February 7, 2014 3:24 PM | 31/12/2013(YR) | 35% (D) - 10% (B) | 21/04/2014 - 28/04/2014 |